Value through Innovation17 January 2013

Diabetes News and Information

This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Diabetes Press Releases

back 1 2 3 4 5 6 7 8 next

28.06.2012	New publication in The Lancet: Two-year study in over 1,500 patients compares Trajenta® (linagliptin) to the commonly prescribed sulphonylurea glimepiride - EX US & UK Medical Media Only
11.06.2012	Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine - EX UK. Medical Media Only.
09.06.2012	New analysis presented at ADA shows improvement in albuminuria with linagliptin in patients at high risk of declining renal function - EX US & UK. Medical Media Only.
09.06.2012	New data demonstrate sustained glucose reduction and weight loss up to 90 weeks with investigational SGLT-2 inhibitor, empagliflozin* - EX US & UK. Medical Media Only.
09.06.2012	New linagliptin phase III data demonstrate significant reductions in blood glucose with no additional risk of hypoglycaemia when combined with insulin in patients with type 2 diabetes - EX US & UK. Medical Media Only.

back 1 2 3 4 5 6 7 8 next

Further Press Releases in our Archive

Diabetes Related News Room

Resources
Videos

Diabetes Related Documents

Diabetes Video Gallery

Mode of Action of DPP-4 Inhibitors
- Watch the Video
Diabetes Complications Animation
- Watch the video
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)